Cargando…
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
BACKGROUND: There have been ongoing efforts to understand when and how data from observational studies can be applied to clinical and regulatory decision making. The objective of this review was to assess the comparability of relative treatment effects of pharmaceuticals from observational studies a...
Autores principales: | Hong, Yoon Duk, Jansen, Jeroen P., Guerino, John, Berger, Marc L., Crown, William, Goettsch, Wim G., Mullins, C. Daniel, Willke, Richard J., Orsini, Lucinda S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647453/ https://www.ncbi.nlm.nih.gov/pubmed/34865623 http://dx.doi.org/10.1186/s12916-021-02176-1 |
Ejemplares similares
-
Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making
por: Berger, Marc L., et al.
Publicado: (2017) -
“Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Willke, Richard J., et al.
Publicado: (2011) -
Methods for the comparative evaluation of pharmaceuticals
por: Zentner, Annette, et al.
Publicado: (2005) -
Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011) -
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
por: Wang, Shirley V., et al.
Publicado: (2022)